Zota Health Care [ZOTA] vs NGL Fine-Chem [NGLFINE] Detailed Stock Comparison

Zota Health Care Limited

NSE
Loading...

NGL Fine-Chem Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Zota Health Care Limited wins in 3 metrics, NGL Fine-Chem Ltd. wins in 16 metrics, with 0 ties. NGL Fine-Chem Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Zota Health Care Limited NGL Fine-Chem Ltd. Better
P/E Ratio (TTM) -62.53 38.56 NGL Fine-Chem Ltd.
Price-to-Book Ratio 12.61 4.57 NGL Fine-Chem Ltd.
Debt-to-Equity Ratio 56.90 29.38 NGL Fine-Chem Ltd.
PEG Ratio -0.59 0.03 NGL Fine-Chem Ltd.
EV/EBITDA -126.59 27.25 NGL Fine-Chem Ltd.
Profit Margin (TTM) -15.37% 7.92% NGL Fine-Chem Ltd.
Operating Margin (TTM) -15.88% 13.44% NGL Fine-Chem Ltd.
EBITDA Margin (TTM) N/A 13.44% N/A
Return on Equity -24.83% 7.48% NGL Fine-Chem Ltd.
Return on Assets (TTM) -12.84% 4.87% NGL Fine-Chem Ltd.
Free Cash Flow (TTM) $-959.42M $-949.49M NGL Fine-Chem Ltd.
Dividend Yield 0.07% 0.26% NGL Fine-Chem Ltd.
1-Year Return 27.17% 190.36% NGL Fine-Chem Ltd.
Price-to-Sales Ratio (TTM) 8.34 3.07 NGL Fine-Chem Ltd.
Enterprise Value $45.66B $14.44B Zota Health Care Limited
EV/Revenue Ratio 9.66 3.23 NGL Fine-Chem Ltd.
Gross Profit Margin (TTM) 60.28% 53.33% Zota Health Care Limited
Revenue per Share (TTM) $157 $723 NGL Fine-Chem Ltd.
Earnings per Share (Diluted) $-23.94 $57.61 NGL Fine-Chem Ltd.
Beta (Stock Volatility) 0.36 0.56 Zota Health Care Limited

Zota Health Care Limited vs NGL Fine-Chem Ltd. Stock Performance Analysis

Loading Price Chart...

ZOTA
NGLFINE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Zota Health Care Limited1.75%3.68%3.22%14.06%-26.10%-17.99%
NGL Fine-Chem Ltd.1.98%17.19%32.28%42.63%133.76%122.63%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Zota Health Care Limited27.17%243.00%632.12%1,248.00%1,248.00%1,248.00%
NGL Fine-Chem Ltd.190.36%86.41%63.13%63.13%63.13%63.13%

Performance & Financial Health Analysis: Zota Health Care Limited vs NGL Fine-Chem Ltd.

MetricZOTANGLFINE
Market Information
Market Cap i₹39.41B₹13.81B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i56,4116,556
90 Day Avg. Volume i53,2656,158
Last Close₹1,246.70₹3,109.30
52 Week Range₹917.20 - ₹1,740.00₹980.00 - ₹3,200.00
% from 52W High-28.35%-2.83%
All-Time High₹1,740.00 (Nov 21, 2025)₹3,200.00 (Jun 15, 2026)
% from All-Time High-28.35%-2.83%
Growth Metrics
Quarterly Revenue Growth0.98%0.43%
Quarterly Earnings Growth1.12%11.29%
Financial Health
Profit Margin (TTM) i-0.15%0.08%
Operating Margin (TTM) i-0.16%0.13%
Return on Equity (TTM) i-0.25%0.07%
Debt to Equity (MRQ) i56.9029.38
Cash & Liquidity
Book Value per Share (MRQ)₹103.04₹485.91
Cash per Share (MRQ)₹1.87₹90.47
Operating Cash Flow (TTM) i₹-1,007,999,000₹206.13M
Levered Free Cash Flow (TTM) i₹-563,984,000₹211.24M
Dividends
Last 12-Month Dividend Yield i0.07%0.26%
Last 12-Month Dividend i₹1.00₹3.50

Valuation & Enterprise Metrics Analysis: Zota Health Care Limited vs NGL Fine-Chem Ltd.

MetricZOTA (Apr 22, 2026)NGLFINE (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-62.5338.56
Forward P/E iN/AN/A
PEG Ratio i-0.590.03
Price to Sales (TTM) i8.343.07
Price to Book (MRQ) i12.614.57
Market Capitalization
Market Capitalization i₹39.41B₹13.81B
Enterprise Value i₹45.66B₹14.44B
Enterprise Value Metrics
Enterprise to Revenue i9.663.23
Enterprise to EBITDA i-126.5927.25
Risk & Other Metrics
Beta i0.360.56
Book Value per Share (MRQ) i₹103.04₹485.91

Financial Statements Comparison: Zota Health Care Limited vs NGL Fine-Chem Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricZOTA (2025)NGLFINE (2025)
Revenue/Sales i2.93B3.63B
Cost of Goods Sold i1.44B1.82B
COGS % of Revenue i49.0%50.2%
Gross Profit i1.49B1.81B
Gross Margin i51.0%49.8%
Research & Development iN/AN/A
Operating Income (EBIT) i-480.90M224.26M
Operating Margin i-16.4%6.2%
EBITDA i-42.20M419.90M
EBITDA Margin i-1.4%11.6%
Pre-Tax Income i-576.44M277.14M
Pre-Tax Income % of Revenue i-19.7%7.6%
Income Tax i-9.06M65.90M
Income Tax % of Revenue i-0.3%1.8%
Net Income (Profit) i-567.39M211.24M
Profit Margin i-19.4%5.8%

Balance Sheet & Liquidity Metrics

MetricZOTA (2025)NGLFINE (2025)
Cash & Equivalents i21.32M5.83M
Total Current Assets i1.84B2.35B
Total Current Assets % of Revenue i62.9%64.8%
Total Current Liabilities i1.01B1.19B
Total Current Liabilities % of Revenue i34.3%32.8%
Long-Term Debt i1.08B253.36M
Long-Term Debt % of Revenue i36.7%7.0%
Total Shareholders Equity i2.27B2.82B
Retained Earnings i-191.89M2.77B
Retained Earnings % of Revenue i-6.5%76.3%
Property, Plant & Equipment i65.25M1.42B

Cash Flow Statement Comparison

MetricZOTA (2025)NGLFINE (2025)
Operating Cash Flow i-1.01B206.13M
Operating Cash Flow % of Revenue i-34.4%5.7%
Capital Expenditures i-459.67M-737.60M
Free Cash Flow i-959.42M-949.49M
FCF Margin i-32.7%-26.2%
Debt Repayment i-140.67MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricZOTANGLFINE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i30.33M6.18M
Float Shares i15.02M1.58M
% Held by Insiders i0.00%72.74%
% Held by Institutions i1.16%0.00%
% Held by Public i98.84%27.26%

Dividend Analysis & Yield Comparison: Zota Health Care Limited vs NGL Fine-Chem Ltd.

MetricZOTANGLFINE
Last 12-Month Dividend i₹1.00₹3.50
Last 12-Month Dividend Yield i0.07%0.26%
3-Year Avg Annual Dividend i₹1.00₹2.33
3-Year Avg Dividend Yield i0.16%0.10%
3-Year Total Dividends i₹3.00₹7.00
Ex-Dividend DateSep 22, 2025Aug 12, 2025